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Abstract
Objective—To examine characteristics associated with perceived benefit from outpatient mental
health services for children and to determine whether perceived benefit is related to continued use
of mental health services at a 6 month follow-up.
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Methods—Eligible children were first time users of the 9 LAMS (Longitudinal Assessment of
Manic Symptoms) clinics, 6–12 years, English speaking with no other child in the household
screened. Parents completed the Parent General Behavior Inventory 10-Item Mania Scale
(PGBI-10M). Children scoring ≥12 were invited to participate and 55% agreed (621/1124). Socio
demographic, diagnostic and services use data were collected at baseline and 6 months including a
question asking parents to rate how much their children had benefited from the most recent
outpatient treatment.
Results—29% of parents reported that the treatment their child was receiving benefited them “a
lot.” At the baseline visit, perceived benefit was related to receiving medication or medication and
therapy as compared to just therapy, higher functioning scores, LAMS site, no comorbid
diagnoses, living with both biological parents and no prior hospitalizations of parents or siblings.
At the six month follow-up, perceived benefit was related to continued outpatient mental health
services use (p<.0001).
Conclusions—Perceived benefit of current treatment is related to type of treatment received;
medication with or without therapy is perceived as more beneficial than therapy alone. Perceived
benefit of treatment is strongly related to continued use of treatment.
Keywords
children’s mental health services; benefit; utilization
Introduction
Mental health problems in children are prevalent, debilitating disorders yet only half of the
children with disorders receive services1,2 and those who do receive services frequently
receive inadequate services.3 Children often come for an evaluation but fail to start
treatment, prematurely terminate services, may not adhere to treatment recommendations
and, given the slow diffusion of evidence-based practices into typical community-based
services, may not receive an efficacious treatment.4–8
Given that children rarely make their own treatment decisions, examinations of barriers to
mental health treatment usually focus on parental and family factors. Although many
theoretical models have been proposed to describe use of mental health treatment, a
particularly useful model for explaining parental engagement has been described by Olin
and colleagues, 2010.9 Using the Unified Theory of Behavior10,11 they proposed that parent
engagement is focused on four primary constructs including beliefs and expectations, social
norms, attitudes and self efficacy. Structural barriers include availability of services,
transportation and insurance while perceptual barriers, include stigma, denial of need for
treatment and questions about the effectiveness of services.12–20 For families who terminate
early concerns about the cultural relevance of services, their comfort engaging with services
and the lack of consideration of family preferences when selecting services appear to be
important factors.5–8 Family treatment preference is especially important for medications,
since many parents, particularly African American parents, prefer psychotherapy over
medication.21–24 Kazdin and colleagues, as well as others, have established that parental
ratings of the relevance of treatment is related to premature termination.5,21,25,26 Further,
parental beliefs in the likely effectiveness of therapy appear to have a curvilinear
relationship to treatment attendance.25
Although similar to parental expectations of treatment effectiveness, largely absent from the
investigation of barriers is attention to perceived benefit of current services even though the
Olin et al model and available data suggest that parent involvement in child mental health
treatment depends on perception of benefit.9 Data suggest that parental perceived risk of
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antidepressants predicts fewer future child medication visits.21 Similarly, parental
expectations are related to perceived barriers to treatment and appear to limit treatment
efficacy.24 Adult data suggest that patients who strongly preferred counseling and did not
receive it were likely to forego treatment completely,23 and that attendance at self-help
groups for families of individuals with mental illness is related to perceived benefits.27
Given the potential importance of parental perceived benefits of treatment early in the
treatment process for utilization of child mental health services, we examined family and
child characteristics related to perceived benefits from outpatient mental health services for
children. Additionally, we examined whether benefit, assessed after the initial treatment
visit, predicted continued outpatient mental health services use over a 6 month follow-up.
Specifically, we tested the hypothesis: Parental rating of “a lot” of benefit from the current
treatment measured early in the care process is related to mental health services use at a six
month follow-up.
Method
Institutional Review Boards at each of the four university-affiliated LAMS sites (Case
Western Reserve University, Cincinnati Children’s Medical Center, the Ohio State
University, and the University of Pittsburgh Medical Center/Western Psychiatric Institute
and Clinic) reviewed and approved all procedures in the protocol. Written informed consent
from parents/guardians and assent from participants were obtained before any study-related
procedures were performed.
Design
Parents/guardians of children between the ages of 6 years, 0 months and 12 years, 11 months
who were new patients to LAMS outpatient clinics, spoke English, whose accompanying
parent/guardian spoke English and who had not had a child living in the same household
previously screened, were asked to complete the Parent General Behavior Inventory 10-Item
Mania Scale (PGBI-10M)28,29 to screen for elevated symptoms of mania. The items that
comprise the PGBI-10M describe hypomanic, manic, and biphasic symptomatology and
have been reported to discriminate bipolar disorder in youth from other diagnoses.29 Each
patient whose parent/guardian rated the child at or above a score of 12 on the PGBI-10M
was invited to participate in the longitudinal portion of the LAMS study. In addition, a
smaller comparison group of patients who scored 11 or lower roughly matched in real time
on age, sex, race, ethnicity, and Medicaid status was selected to enroll in the longitudinal
portion of the study. More details concerning participant ascertainment and the rationale for
the cut score of 12 on the PGBI-10M are described in Horwitz et al.30 and Findling et al.31
Of the 1124 children with elevated symptoms of mania (≥12 on the PGBI-IOM), 621 or
55% accepted the invitation. There were no statistically significant sociodemographic
differences (age, sex, race/ethnicity, insurance type) between children/families who did and
did not agree to enroll in the longitudinal study. Children without elevated symptoms of
mania (≤ 11 on the PGBI-IOM) were sampled with replacement (those who were
approached, but refused, were replaced by another demographically matched youth scoring
≤ 11) resulting in 86 children without symptoms of mania also being included in the
longitudinal cohort.30 Baseline assessments were completed after the initial visit to the clinic
and participants who continued to be eligible were seen every six months. At 6 months, 678
children (96%) remained eligible and the 573 with baseline benefit and treatment data (85%)
were included in these analysis. Children in the LAMS study received treatment as usual
initiated during their visit first to participating clinics.
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Demographics—Parents/guardians provided information on age, sex, race, ethnicity,
parental education, health insurance status, whether the child was living with both biological
parents and medical history.
Diagnoses—Children and their guardians were administered the Schedule for Affective
Disorders and Schizophrenia for School-Age Children-Present and Lifetime Episode (K-
SADS-PL)32 with additional depression and manic symptom items derived from the
Washington University in St. Louis Kiddie Schedule for Affective Disorders (WASH-U K-
SADS).33,34 Items to assess nonverbal communication, the child’s relationship with others,
shared enjoyment, and social-emotional reciprocity according to DSM-IV criteria were
added to the KSADS-PL to screen for pervasive developmental disorders. The resulting
instrument, the K-SADS-PL-W, is a semi-structured interview that assesses current and
lifetime psychiatric diagnoses and the time course of each illness.
Unmodified DSM-IV diagnostic criteria were used in the LAMS study. The criteria for BP-
NOS were clarified for the LAMS study to follow the same criteria used in the Course and
Outcome of Bipolar Youth study (COBY).35 All diagnoses were reviewed and confirmed by
a licensed child psychiatrist or psychologist.
Medication History—Each child’s parent/guardian provided a complete history of the
child’s past and currently prescribed psychotropic medications during the interview.
Functional Assessment—The Children’s Global Assessment Scale (CGAS) was
completed by study interviewers to provide a severity rating of participants’ current
impairment.36
Unfiltered manic and behavioral dysregulation was assessed by parent report on the
PGBI-10M and the Young Mania Rating Scale (YMRS).37 Filtered ratings of manic
symptoms were rated on the K-SADS Mania Rating Scale (KMRS).38 Unfiltered depressive
symptoms were measured by the Children’s Depression Rating Scale-Revised.39 Filtered
ratings of depressive symptoms were rated on the K-SADS Depression Rating Scale
(KDRS).
Family Factors—Parent self reported mental health diagnoses as well as those for 1st and
2nd degree relatives were collected using the Modified Family History Screen.40 Parents
were asked whether they or any of the study child’s siblings had received treatment or had
been hospitalized for an emotional or behavioral problem. Parental stress was assessed by
the Parent Stress Survey,41 and parental burden was assessed through 13 items from the
Parent Stress Survey.41
Mental Health Services Use—The Services Assessment of Children and Adolescents
(SACA) was completed at baseline and at each follow-up. The SACA documents mental
health services use for inpatient, outpatient and school settings with detailed data on
inpatient and outpatient services with excellent reliability and validity.42–44 Parents were
asked about the most recent treatment children received (medication, therapy, medication
and therapy or just an evaluation), to rate how well the most recent outpatient services
matched their child’s needs (not well, somewhat, very well) and how much their child had
benefited from the most recent treatment (not at all, some, a lot). This last question served as
an outcome for these analyses. The responses were dichotomized to examine the factors
related to parents’ perceptions of benefits of treatment (a lot versus some/not at all) and
because in these analysis the some/not all responses showed similar patterns of relationships.
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The SACA was used at the 6 month follow-up visit to establish whether children remained
in services (scored yes or no).
Statistical Analyses
SAS version 9.2 was used to analyze the data; alpha was set at .05, and two-tailed tests were
used for all analyses. Child and family characteristics were described using counts and
proportions for categorical variables, medians, 25th and 75th percentile for skewed variables
and means and standard deviations for normally distributed continuous measures. Bivariate
associations of child and family characteristics with each outcome of interest were examined
using univariable logistic regression analyses. Post-hoc pairwise comparisons were
examined if the overall p-value was statistically significant; given the descriptive nature of
the bivariate analyses, no adjustments were made for multiple comparisons. Multivariable
logistic regression examined adjusted associations of child and family characteristics with
each outcome, with site included as a design variable. The first model (model 1) of parent
perception of benefit included site and the three clinical measures of interest: primary
diagnosis, treatment, baseline child functioning; model 2 included those measures plus child
and family characteristics that were statistically significantly related to parent perception of
benefit in the bivariate analysis and days between screening (the initial clinic visit) and
baseline assessment. The relation of parent perception of benefit from most recent treatment
with continuation of treatment for six months was examined using a similar method. Model
1 included parent perception of benefit and site while model 2 additionally included child
and family characteristics that were significantly related to continuation of treatment in the
bivariate analysis. Results of the logistic regression analyses are summarized using adjusted
odds ratios (aOR) and 95% confidence intervals (CI).45
Results
Characteristics Associated with Perceived Benefit
Baseline characteristics for the entire sample and stratified by perceived benefit from
treatment at baseline and continuation of treatment for six months are shown in Tables 1–3.
Twenty nine percent (n=167) of the 573 parents reported that the treatment their child was
receiving benefited them a lot, while 52% (n=299) reported some benefit and 19% (n=107)
reported no benefit. Children living with both biological parents were more likely to have
parents who reported benefit from most recent outpatient mental health treatment compared
to children who lived with one or neither biological parent (36% vs. 26%, p=.01). Child
clinical characteristics were consistently related to parent reported treatment benefit.
Children with a primary diagnosis of Bipolar or Psychotic Disorders, Anxiety, or
uncomplicated ADHD were more likely to have parents who reported considerable benefit
compared to children with Disruptive Behavior Disorders. Children with a Depressive
Disorder were less likely to have parents who rated their treatment as very beneficial
compared to children with ADHD (26% vs. 41%, p=.03). Those children without comorbid
diagnoses and fewer diagnoses had parents who were more likely to rate the most recent
treatment as beneficial. Children who were only receiving psychosocial therapy were half as
likely to have parents rate their most recent treatment as beneficial compared to children
who were receiving medication with or without therapy (19% vs 36% and 35% respectively,
p<.001).
Parents were more likely to rate treatment as beneficial if their child had higher C-GAS
scores, lower CDRS-R scores and no immediate family member who had been hospitalized
for a mental health problem. Parents in Cleveland were twice as likely to rate mental health
services as beneficial (52% vs. 19%, 27% and 21%; all p<.001) compared to parents in the
other three sites. There were no statistically significant differences in ratings of benefit
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among the three other sites. Finally, the proxy measure of length of treatment, days between
screening and the baseline interview, was positively associated with benefit.
Table 4 shows the results of the multivariable modeling of parent perception of a lot of
benefit. Although diagnosis was no longer significantly related to perceived benefit of
previous treatment, the other factors were (model 1). Compared to therapy alone, parents of
children receiving medication had 1.81-fold increased odds of reporting considerable benefit
(CI: 1.07–3.07) and parents of children receiving medication and therapy in combination
had more than two-fold increased odds (aOR=2.17, CI: 1.31–3.58; overall p-value < .009).
Similarly, functioning as measured by the C-GAS remained related to perceived benefit such
that each 5-point increase in C-GAS score was associated with a 21% increased odds of
perceived benefit (aOR=1.21, CI=1.07–1.36; p=.003). Model 2 also indicated that parents of
children with no comorbid diagnoses had almost twice the odds of perceiving their treatment
as beneficial (aOR=1.91; 95% CI=1.03–3.56; p=.04). Other factors remaining associated
with perceived benefit in the model included site, living with both biological parents and
never having had an immediate family member hospitalized for a mental health problem.
We next examined characteristics associated with remaining in services at the six month
follow-up (Tables 1–3). Three-quarters of the children (n=435; 76%) continued to receive
outpatient mental health services at the six-month follow-up. No child demographic
characteristic including race/ethnicity was associated with continuation of treatment.
Children who lived with both biological parents were more likely to continue outpatient
treatment compared to children who lived with one or neither biological parent (83% vs.
73%, p=.01). A smaller proportion of children with Medicaid insurance continued outpatient
treatment for six months compared to children who did not have Medicaid insurance (71%
vs. 81%, p=.003). None of the child clinical characteristics at baseline were significantly
related to continuation of treatment but clinical characteristics of the family, including fewer
parent mental health problems (4.5 vs. 5.5, p=.02) and neither parents nor siblings having
ever been hospitalized for a mental health problem (79% vs. 70%, p=.02), had positive
associations with continuation of treatment. A majority (83%) of parents who perceived a lot
of benefit from their child’s most recent outpatient mental health treatment reported that
their child continued with treatment for six months; fewer children continued with treatment
if their parents perceived only “some” benefit (78%) or no benefit (60%).
The multivariable model predicting continued use of treatment showed that perceived
benefit of treatment was significantly related to continued treatment at six months after
adjusting for site (Table 5). Parents who perceived a lot of benefit from treatment had a 1.91
fold increased odds (CI: 1.19–3.08) of continuing treatment for six months compared to
those who perceived some/no benefit. The only other baseline characteristic that was
significantly associated with continuation of treatment for six months was living with both
biological parents (aOR=1.59, CI: 1.00–2.52) (model 2).
Discussion
These analyses suggest that perceived benefit early in treatment may be an important
predictor of remaining in treatment and that multiple factors are correlated with parents’
perceptions of the benefit of treatment. Parents perceive treatment to be beneficial when
their children’s functioning is higher and when they have fewer symptoms as previously
suggested in the literature.24 Surprisingly, among the previously identified
sociodemographic variables associated with perceived efficacy of treatment,21,24 only living
with both biological parents was related to perceived benefit in this study population.
Perhaps most striking was the association with benefit of receiving medication or
medication and therapy as compared to therapy alone, similar to the MTA findings.46 Given
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the reported preference of parents, particularly minority parents, for counseling over
medication18,24 this endorsement of benefit for medication may indicate that parents
suspend their concerns about potential side effects when they believe medications have lead
to improvements in their children. Interestingly, race/ethnicity was not related to perceived
benefit from treatment or continuing treatment at six months. In fact, African American and
White children continued in treatment similarly (74% and 76% respectively) as did Latino
and other/mixed race children (82% and 79%). This suggests that the often reported early
termination of treatment by non-white children and families may be service-setting specific.
The relationship of perceived benefit to remaining in treatment, although not the same as, is
consistent with Nock et al’s finding that parent expectancies are related to premature
termination.24 Thus, as suggested by Olin et al9 discussing parents’ perceptions of the
benefits their children are receiving from treatment early in the treatment process may be a
useful strategy to prevent premature termination.47 Parental engagement in their children’s
mental health treatment has been shown to increase utilization and seeking input about
treatment benefit may be an important part of such engagement.9,48
As with all data, these have certain limitations. This is a cohort of outpatient utilizers that is
enriched for symptoms of mania and collected in one geographical region. These children
may not be representative of all users of child outpatient mental health services. Not all
members of the study population had baseline treatment and benefit data although we could
identify no child, family or clinical differences between those with and without these data.
These treatment-utilization data are self report and no data were verified. Benefit from
treatment consisted of one question and we collected no data on the quality of care children
received from clinic records. The absence of data on the care received is important because
of the differences in perceived benefit of treatment in Cleveland compared to the other sites.
Because these children were recruited from outpatient mental health clinics, these data also
provide no information on factors important for initially seeking services.
The relationship of perceived benefit from treatment to continued use of treatment is an
important finding and one that could be used to develop strategies to engage families in
treatment. Given the paucity of interventions that improve engagement and retention
exploration of perceived benefit is warranted.49 Future studies should also consider the
child’s perception of benefit50,51 as well as the interaction of parental and child perceptions
of benefit. With efficacious mental health treatments available, initiating and maintaining
children in treatment is critically important for assuring that they receive the care that
potentially could improve their health.
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